Britannia Life Sciences Inc. (CSE:BLAB)

Canada · Delayed Price · Currency is CAD

0.1000

+0.0050 (5.26%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Medical Labs & Research	369.28K	516.83K	6.40M	7.30M	1.42M
Medical Labs & Research Growth	-28.55%	-91.93%	-12.28%	412.42%	-
Total	369.28K	516.83K	6.40M	7.30M	1.42M
Total Growth	-28.55%	-91.93%	-12.28%	412.42%	-

Revenue by Geography

Financials in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
United States	369.28K	516.83K	6.40M	7.30M	1.42M
United States Growth	-28.55%	-91.93%	-12.28%	412.42%	-
Total	369.28K	516.83K	6.40M	7.30M	1.42M
Total Growth	-28.55%	-91.93%	-12.28%	412.42%	-

Source: S&P Global Market Intelligence.